You are here

TB Noon Conference

About the Meetings

Dr. Jonathan GolubThe Center for TB Research’s TB Clinical and Epidemiology Meeting is a weekly exchange of ideas, results, and topical news in the field. This meeting is led by Dr. Jonathan Golub and Dr. Richard Chaisson, and brings together JHU TB researchers and trainees. These meetings serve to keep our group of TB researchers up-to-date in all realms of TB research, as presentations vary from basic science to drug development and discovery to epidemiology.

For more information about these sessions, contact Dr. Jonathan Golub, or Dr. Richard Chaisson.


TB Noon Conference (6-4-15)

Description: 

Dr. Carlton Evans provides an overview of two studies that have provided socioeconomic support as a TB control intervention.

Speaker: 
Carlton Evans
Posted: 
June 4, 2015

TB Noon Conference (5-7-15)

Description: 

Dr. Neil Martinson presents the methods of tracing contacts of index tuberculosis (TB) cases in both adults and children that have been utilized in South African studies.

Speaker: 
Neil Martinson
Posted: 
May 7, 2015

TB Noon Conference (4-23-15)

Description: 

MPH candidate Mariana Soares Puppin presents her thesis project, describing which participants of the THRio study received either a tuberculin skin test and isoniazid preventive therapy (IPT).

Speaker: 
Mariana Soares Puppin (MPH candidate)
Posted: 
April 23, 2015

TB Noon Conference (4-23-15)

Description: 

MPH candidate and medical student Robert Bonacci presents another aspect of the THRio study, this time looking at recurrent TB and death.

Speaker: 
Robert Bomacco (MPH candidate)
Posted: 
April 23, 2015

TB Noon Conference (4-16-15)

Description: 

Liza Bronner Murrison presents an evaluation of delays in TB diagnosis for patients accessing care in the private sector, in Chennai, India. 

Speaker: 
Liza Bronner Murrison
Posted: 
April 16, 2015

TB Noon Conference (2-12-15)

Description: 

Over the course of this lecture Dr. Kelly Dooley describes a planned trial for novel treatment of TB meningitis in children after covering TB in children, TB meningitis, and the approach that led to the TBM-KIDS trial design.
 

Speaker: 
Kelly Dooley, MD
Posted: 
February 12, 2015

TB Noon Conference (1-29-15)

Description: 

In this lecture, Dr. Jaques Grosset describes his effort to reproduce results of a multi-drug TB treatment regimen that utilized Clofazimine for treating patients with drug resistance, using the mouse model.

Speaker: 
Dr. Jacques H. Grosset
Posted: 
January 29, 2015

TB Noon Conference (11-20-14)

Description: 

In this lecture, Dr. Richard Chaisson describes the design of three recent trials that were initiated to study options for shortening TB treatment (both individual drugs and regimens)...

Speaker: 
Dr. Richard Chaisson and Dr. Eric Nuermberger
Posted: 
November 20, 2014

TB Noon Conference (10-9-14)

Description: 

Sarah Bur provides an overview of incarceration in the US and reviews TB and TB control in prisons.
 

Speaker: 
Sarah Bur, RN, MPH
Posted: 
October 9, 2014

TB Noon Conference (7-3-14)

Description: 

In this lecture, Dr. Adolfo Cambule describes community-based programs in Mozambique that have made an impact on TB control.
 

Speaker: 
Dr. Adolfo Cambule
Keywords: 
Posted: 
July 3, 2014

TB Noon Conference (6-25-14)

Description: 

Dr. Evans shares the research findings from IFHAD, the Innovation For Health And Development research group, and discusses why socioeconomic development drives TB rates more that TB control programs.

Speaker: 
Dr. Carlton Evans
Keywords: 
Posted: 
June 25, 2014

TB Noon Conference (4-24-14)

Description: 

Inflammatory Markers and Incident TB: An International Case-control Study
In this lecture Dr. Amita Gupta presents data from a study nested within a larger clinical trial to evaluate inflammatory markers and the risk of incident TB. She concludes with potential ways forward, including the possibility of developing a risk score for use in larger studies.

Speaker: 
Dr. Amita Gupta
Keywords: 
Posted: 
April 24, 2014

TB Noon Conference (3-27-14)

Description: 

Considerations for 4-month Treatment of Culture-Negative Pulmonary Tuberculosis
This lecture explores the implications of treating uncomplicated sputum culture negative pulmonary TB for four months, versus the standard six months.  The lecturer, Dr. Yohhei Hamada, also examines some of characteristics of patient profiles that would be appropriate for this regimen, including HIV status.

Speaker: 
Dr. Yohhei Hamada
Keywords: 
Posted: 
March 27, 2014

TB Noon Conference (2-27-14)

Description: 

Tuberculosis Control in the Tibetan Population
in India - (part 1)

This introduction, presented by Dr. Tsetan Sadutshang, highlights the history of medical care for Tibetans living in exile in India, particularly the persistent problem of tuberculosis.  High quality medical care that meets the needs of a migratory refugee population has been particularly challenging, but volunteers and external donors have sustained a system that meets the unique needs of of Tibetans who are at high risk of contracting TB.

Speaker: 
Dr. Tsetan D. Sadutshang
Keywords: 
Posted: 
February 27, 2014

TB Noon Conference (2-27-14)

Description: 

Tuberculosis Control in the Tibetan Population
in India - (part 2)

In this section of the lecture Dr. Kunchok Dorjee describes the growth of the TB control program based out of Delek hospital.  Their TB program has recorded some of the highest rates of TB incidence, and through partnerships with JHU and AISPO, the program has collected rigorous data, employed active case finding strategies, and enacted comprehensive treatment programs that have yielded dramatically improved cure rates, even for drug resistant strains of the disease.

Speaker: 
Dr. Kunchok Dorjee
Keywords: 
Posted: 
February 27, 2014

TB Noon Conference (1-30-14)

Description: 

Will New TB Diagnostics Make a Difference?Roundtable Discussion on the Role of Clinical/Empiric Diagnosis
This interactive session utilizes the opinions of TB researchers at Hopkins as they respond to data that show how novel tools impact global estimates.  As stand-alone developments, even the most promising tools of TB control, such as GeneXpert, are not magic bullets that can reverse the epidemic.

Speaker: 
Dr. David Dowdy
Keywords: 
Posted: 
January 30, 2014

TB Noon Conference (1-9-14)

Description: 

DR-TB Treatment in Children: Early Evidence from Clinical and Pharmacokinetic Studies in South Africa
Most global and country estimates of the drug-resistent TB likely underestimate the burden in children.  Approximately one million children per year may be exposed to MDR-TB.  This lecture examines the epidemiology and treatment outcomes of MDR-TB in children in a high burden setting in South Africa, and also questions what drug regimens may be best suited for children based on new evidence.

Speaker: 
Dr. Anneke C. Hesseling
Keywords: 
Posted: 
January 9, 2014

TB Noon Conference (12-19-13)

Description: 

Overview of the Drug-resistant TB Sub-Programme and MDR-TB Research in South Africa
"TB and HIV are one in the same disease" - such is the case in South Africa, where co-infection with both diseases is high.  Drug resistant TB is a major problem and leading priority in four of the country's provinces . This lecture highlights some of the novel approaches in care and infection control that the health ministry is taking to address a tremendous disease burden

Speaker: 
Dr. Norbert Ndjeka
Keywords: 
Posted: 
December 19, 2013

TB Noon Conference (12-12-13)

Description: 

The Roadmap for Childhood Tuberculosis: New Approaches and Direction
Diagnosing TB in children is difficult in even the most resourced settings.  In this lecture we explore the importance of obtaining accurate clinical measures and the need to include pediatric diagnosis and treatment at the forefront of TB control programs.

Speaker: 
Dr. Jeffrey R. Starke
Keywords: 
Posted: 
December 12, 2013

TB Noon Conference (12-5-13)

Description: 

Prediction and Implications of TB Treatment Default in Urban Morocco
Are patients who default at high risk of transmitting TB?  Is drug resistance common among patients who return to care after TB treatment default?

Speaker: 
Dr. Kelly Dooley
Keywords: 
Posted: 
December 5, 2013

TB Noon Conference (11-14-13)

Description: 

Tuberculosis Control in Nigeria: A Report from NTP
1).  An overview of the strategic approach for GeneXpert MTB/RIF implementation and results from Nigeria.  2).  Is the NTP on track in reaching its set targets?  An evaluation of the NSP in 2013.

Speaker: 
Dr. Nkem Chukwueme
Keywords: 
Posted: 
November 14, 2013

TB Noon Conference (10-24-13)

Description: 

Tuberculosis in the ICU: A Retrospective Study in a Low Burden Setting
What is the typical profile of the patients admitted into the ICU for tuberculosis?  Based on this data, can we improve outcomes for these patients?

Speaker: 
Dr. Jean-Philippe Lanoix
Keywords: 
Posted: 
October 24, 2013